Chemotherapy-induced Cardiotoxicity
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Cardiotoxicity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity [NA]
A Nazarbayev University study is evaluating grape polyphenols for prevention of chemotherapy-induced cardiotoxicity in breast cancer patient…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Cardioprotection on Chemotherapy-Induced Cardiotoxicity [Phase 3]
A Phase 3 clinical trial evaluating a cardioprotective strategy to prevent chemotherapy-induced cardiotoxicity is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Myocardial Perfusion and Fibrosis in Cancer Survivors
This completed clinical trial from Virginia Commonwealth University studied myocardial perfusion and fibrosis in cancer survivors, focusing …
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether rosuvastatin can protect against chemotherapy-induced cardiotoxicity in HER2-positive breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity [Phase 3]
Phase 3 trial evaluating bisoprolol to prevent anthracycline-induced cardiotoxicity has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity [Phase 3]
Phase 3 trial evaluating carvedilol to prevent chemotherapy-induced cardiotoxicity in patients with breast cancer and heart failure.